Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 40 year old male with newly diagnosed moderate UC and articular extraintestinal manifestations
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 70 year old female with newly diagnosed severe UC
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 35 year old male with known moderate UC with prior exposure to infliximab but has worsening colitis on endoscopy despite compliance
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 60 year old female with newly diagnosed moderate UC with a background of congestive cardiac failure
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 38 year old female with newly diagnosed moderate UC and psoriasis
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 25 year old pregnant woman with severe distal ulcerative colitis
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 56 year old man with moderate to severe ulcerative colitis and ankylosing spondylitis
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 38 year old man with severe ulcerative colitis and has lost response to vedolizumab
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 28 year old woman who has severe extensive ulcerative colitis and has a history of lymphoma which was treated 4 years ago
Recommend biological drugs for treatment of moderate to severe ulcerative colitis given the following patient profile:\n 36 year old woman with moderate ulcerative colitis and multiple sclerosis